Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease
Comparison of Exercise Capacity, Muscle Oxygenation and Physical Activity Levels Between Patients With Interstitial Lung Disease and Healthy Individuals
1 other identifier
observational
40
1 country
1
Brief Summary
Interstitial lung diseases (ILD) are a group of chronic respiratory diseases that cause significant mortality and morbidity worldwide. Although there are studies in the literature comparing different lung disease groups with healthy individuals, it has been determined that there is no study comparing the exercise capacity, muscle oxygenation, physical activity level, respiratory functions, respiratory and peripheral muscle strength, inspiratory muscle endurance, quality of life and sleep quality of individuals diagnosed with ILD with healthy individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2024
CompletedFirst Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
April 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2025
CompletedApril 29, 2025
February 1, 2025
7 months
April 22, 2025
April 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Maximal exercise capacity
Maximal exercise capacity will be assessed by symptom-limited cardiopulmonary exercise testing on a treadmill at gradually increasing workload, and oxygen consumption will be measured during the test.
Trough study completion, an average of 1 year
Muscle Oxygenation
Muscle oxygenation before, during and after exercise tests will be measured with a near-infrared spectroscopy device.
Trough study completion, an average of 1 year
Physical Activity Level
Individuals' physical activity level will be assessed with a multi-sensor physical activity monitor.
Trough study completion, an average of 1 year
Secondary Outcomes (13)
Upper extremity functional exercise capacity
Trough study completion, an average of 1 year
Lower extremity functional exercise capacity
Trough study completion, an average of 1 year
Dyspnea
Trough study completion, an average of 1 year
Respiratory Muscle Strength
Trough study completion, an average of 1 year
Inspiratory muscle endurance
Trough study completion, an average of 1 year
- +8 more secondary outcomes
Study Arms (2)
Patients with ILD
That group consists of patients who had been diagnosed with ILD by doctors. Oxygen consumption using CPET, muscle oxygenation with a near-infrared spectroscopy device, physical activity level using multi-sensor activity monitor, pulmonary function using spirometer, lower extremity functional exercise capacity with 6MWT, upper-extremity functional exercise capacity with 6PBRT, respiratory muscle strength using mouth pressure device, peripheral muscle strength with hand-held dynamometer, inspiratory muscle endurance using incremental threshold loading test, dyspnea with 'Modified Medical Research Council' Dyspnea Scale and 'Turkish version of London Chest Daily Living Activity Scale', dyspnea at rest, during, and after exercise training with 'Modified Borg Scale', disease-related quality of life with 'Turkish version of Saint George Respiratory Questionnaire' and sleep quality with 'Pittsburg Sleep Quality Index' will be evaluated in patients with ILD.
Healthy Controls
That group consists of people who have not been diagnosed with a disease. Oxygen consumption using CPET, muscle oxygenation with a near-infrared spectroscopy device, physical activity level using multi-sensor activity monitor, pulmonary function using spirometer, lower extremity functional exercise capacity with 6MWT, upper-extremity functional exercise capacity with 6PBRT, respiratory muscle strength using mouth pressure device, peripheral muscle strength with hand-held dynamometer, inspiratory muscle endurance using incremental threshold loading test, dyspnea with 'Modified Medical Research Council' Dyspnea Scale and 'Turkish version of London Chest Daily Living Activity Scale', dyspnea at rest, during, and after exercise training with 'Modified Borg Scale', disease-related quality of life with 'Turkish version of Saint George Respiratory Questionnaire' and sleep quality with 'Pittsburg Sleep Quality Index' will be evaluated in healthy controls.
Eligibility Criteria
Patients diagnosed with ILDs and healthy individuals
You may qualify if:
- Patients diagnosed with ILD according to ATS/ERS criteria,
- Ages between 18 and 75,
- Pulmonary infection during the previous month,
- Participants who voluntarily participated in the study were included.
You may not qualify if:
- Patients were excluded if they had:
- Acute pulmonary exacerbation or respiratory infection in the last four weeks
- Obstructive lung disease
- Systemic conditions affecting neurological, neuromuscular, orthopedic, or physical functions
- Recent participation in a planned exercise program (within three months)
- Cognitive impairment affecting exercise test understanding
- Contraindications to exercise testing per the American Sports Medicine Association
- Cancer, renal, or hepatic disease
- Aortic stenosis, complex arrhythmia, or aortic aneurysm
- Serious cardiovascular diseases like uncontrolled hypertension, diabetes, heart failure, or arrhythmia
- For healthy individuals who will participate in the study;
- No diagnosed chronic disease,
- Healthy adults between the ages of 45-80
- Individuals with a Mini Mental State Assessment Scale score of less than 24,
- A smoking history of at least 10 packs×years or more,
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, 06490, Turkey (Türkiye)
Related Links
- Ward J, McDonald C. Interstitial lung disease - An approach to diagnosis and management. Aust Fam Physician. 2010;39(3):106-10. PubMed PMID: 20369109.
- Cakmak A, Inal-Ince D, Sonbahar-Ulu H, Bozdemir-Ozel C, Ozalp O, Calik-Kutukcu E, et al. Physical activity of patients with bronchiectasis compared with healthy counterparts: A cross-sectional study. Heart Lung. 2020;49(1):99-104. Epub 20190914. doi: 10.
- Arikan H, Yatar I, Calik-Kutukcu E, Aribas Z, Saglam M, Vardar-Yagli N, et al. A comparison of respiratory and peripheral muscle strength, functional exercise capacity, activities of daily living and physical fitness in patients with cystic fibrosis and
- Fırat M, Mutlu Ş, Yoleri B, Boşnak Güçlü M. Comparison of respiratory functions, muscle strength, and physical activity among children with primary ciliary dyskinesia with and without Kartagener's syndrome and healthy controls. Physiother Theory Pract. 2
- Garcia T, Mantoani LC, Silva H, Zamboti CL, Ribeiro M, Ramos EMC, et al. Characteristics of Skeletal Muscle Strength in Subjects With Interstitial Lung Disease. Arch Phys Med Rehabil. 2024;105(6):1099-105. Epub 20240124. doi: 10.1016/j.apmr.2024.01.006.
- Wallaert B, Monge E, Le Rouzic O, Wémeau-Stervinou L, Salleron J, Grosbois J-M. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest. 2013;144(5):1652-8.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
Gazi University
- PRINCIPAL INVESTIGATOR
Nazire Nur YILDIZ, M.Sc.
Nigde Omer Halisdemir University
- PRINCIPAL INVESTIGATOR
Meral BOŞNAK GÜÇLÜ, Prof. Dr.
Gazi University
- PRINCIPAL INVESTIGATOR
Beyzanur ÖYMEZ
Gazi University
- PRINCIPAL INVESTIGATOR
Ayşenur GÜVENİR, M.Sc.
Yozgat Bozok University
- PRINCIPAL INVESTIGATOR
Nilgün YILMAZ DEMİRCİ, Prof. Dr.
Gazi University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
April 22, 2025
First Posted
April 29, 2025
Study Start
December 12, 2024
Primary Completion
July 12, 2025
Study Completion
September 12, 2025
Last Updated
April 29, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
To protect patient data, it will not be shared.